| Attended posters |
| Posters will be on display in Hall 2. Please
note that even-numbered posters will be attended on Tuesday 25 March at
12.15 - 13.15 and odd-numbered posters will be attended on Wednesday 26
March at 12.15 - 13.15. |
Bone |
| P1 |
Osteoblastic
gene expression in cells of the adipocytic lineage
Ioannidou-Kadis S, Staley W, Byers RJ, Selby PL, Freemont AJ & Hoyland
JA |
| P2 |
Effect
of active acromegaly on parathormone circadian rhythm and phosphocalcium
metabolism
White HD, Ahmad AM, Whittingham P, Peter R, Prabhakar K, Durham
BH, Fraser WD & Vora JP |
| P3 |
Functional
and association studies of calcium sensing receptor polymorphisms and
mediators of calcium homeostasis
Harding B, Curley AJ, Christie PT, Bowl MR, Turner JJO, Barber M,
Hampson G, Spector T & Thakker RV |
| P4 |
Hormone
replacement treatment (HRT) increases circulating insulin-like growth
factor binding protein-4 concentration
Heald AH, Kaushal K, Durrington P, Selby P & Gibson JM |
| P5 |
Determination
of a correlation between release of beta c-terminal telopeptides and
area of resorption by recombinant rankl-generated human osteoclasts
Chan BYY, Buckley KA, Dutton J, Gallagher JA & Fraser WD |
| P6 |
Parathyroid
responsiveness to parathyroid hormone (1-34) infusion is altered in adult
growth hormone deficiency following growth hormone replacement
Ahmad AM, Thomas J, White HD, Hopkins MT, Durham BH, Fraser WD & Vora
JP |
| P7 |
Effects
of thyroid hormone (T3) on fibroblast growth factor signalling in bone
Barnard JC, Williams AJ, Harvey CB & Williams GR |
| P8 |
IGF-I
reverses dexamethasone induced growth retardation in mouse embryonic
metatarsal cultures
Mushtaq T, Farquharson C, Seawright E & Ahmed SF |
| P9 |
Comparison
of PTH concentration and phosphocalcium metabolism in treated adult growth
hormone deficient patients with normal and reduced bone mineral density
White HD, Ahmad AM, Corlett P, Syed AA, Patwala A, Durham BH, Vora
JP & Fraser WD |
| P10 |
The
short stature homeobox containing gene (SHOX) inhibits alkaline phosphatase
(ALP) production by C3H10T1/2 cells treated with retinoic acid (RA)
Blair JC, Sitara D, Milligan TP, Burrin JM & Clark AJL |
| P11 |
Effects
of growth hormone replacement on parathyroid gland responsiveness to
hypo- and hyper-calcaemic stimuli in adult growth hormone deficiency
Ahmad AM, Thomas J, White HD, Hopkins MT, Durham BH, Vora JP & Fraser
WD |
| P12 |
Iranian
national osteoporosis prevention plan-1 (inop-1): Preliminary report:
relationship between vitamin D deficiency and markers of bone metabolism
in urban 20-69 year-olds in Tehran, Iran
Pajouhi M, Larijani B, Hashemipour S, Adibi H, Shafaee A, Sedaghat
M & Khalilifard A |
| P13 |
Hypophosphatemic
rickets as a consequence of pregnancy: A case report
Jamieson A |
Clinical case reports |
| P14 |
Combined
pituitary hormone deficiency (CPHD) with adult-onset corticotropin deficiency
but without evidence for PROP-1 or HESX1 mutations
Hammer F, Hahner S, Allolio B & Arlt W |
| P15 |
Rapid
enlargement of thyroid neck swelling in two patients with thyroid dysfunction
Campbell HJ, Kapoor D, Thomas WEG & Jones TH |
| P16 |
Recurrent
ovulation from an ovo-testis in 46XX/47XXY (mosaic) hermaphroditism:
Serial high-resolution ultrasound characterisation
Barber TM, Ball SG & Elliott ST |
| P17 |
A
novel DAX-1 gene mutation with adrenal hypoplasia congenita, differing
degrees of hypogonadism and decreased bone mineral density
Abdalla T, Owen A, Curtis A & Wilton A |
| P18 |
Gender
identity disorder in an Irish population
De Gascun C, Kelly J & O'Shea D |
| P19 |
Addisonian
crisis in a patient with a progressive polyneuropathy
Lewandowski KC, Al-Din A, Spencer N, Andrew J, White C, Nagi DK & Jenkins
RC |
| P20 |
Large
parathyroid adenomas associated with vitamin D deficiency - quaternary
hyperparathyroidism?
Brain HPS, Bano G, Kiely PDK, Sharma AK & Nussey SS |
| P21 |
The
Pituitary Foundation: A national patient support group
Carson MN & Lightman SL |
| P22 |
A
little hard to swallow: A rare cause of dysphagia in scleroderma
Wright KZ, Albon LM & Gittoes NJL |
| P23 |
Cushing's
disease in adolescence
Dale JE, McGregor EJ, Johnson AP, Toogood AT, Shaw NJ, Anderson
JM & Stewart PM |
| P24 |
Vanishing
bone: Stabilisation of Gorham-Stout disease during antiresorptive therapy
Hammer F, Wesselmann U, Tunkel J, Arlt W & Allolio B |
| P25 |
An
unusual presentation of hypopituitarism
Boyle JG, Deans KA & Hopkinson HE |
| P26 |
'My
feet are killing me!' An unusual presentation of Cushing's syndrome
Albon LM, Rippin JD & Franklyn JA |
| P27 |
Delayed
carbimazole induced agranulocytosis precipitating thyroid crisis
Srinivas U, Stanaway S, Worth R & Ewins D |
| P28 |
Fatal cardiac arrest in a woman with thyrotoxic crisis and
sarcoidosis
Badman MK, Al-Izzi MS & Winocour PH |
| P29 |
Complimentary
hyponatraemia
Browne DL & Krentz AJ |
| P30 |
Failure
of metformin and pioglitazone in the treatment of congenital generalised
lipodystrophy
Browne DL, Arundel F & Meeking DR |
| P31 |
Tumour
metastases following laparoscopic resection of adrenal cortical carcinoma
Imtiaz KE, Nirodi GN, Wallis SC & Mughal MM |
| P32 |
Infantile
methylmalonic aciduria caused by maternal pernicious anaemia
Wills CJ & Page RC |
| P33 |
80
years of hyperandrogenism
Evans PA, Wilkin TJ, Millward BA & Flanagan DE |
| P34 |
Developing
an Endocrine Nurse Specialist post can improve service to patients with
endocrine disease
Munday LJ, Wotherspoon F & Meeking DR |
| P35 |
Steroid
responsive hypervitaminosis D due to sarcoid myopathy
Barnor Q, Haq M, Al-Memar A & Spring M |
| P36 |
Clear
cell ovarian adenocarcinoma presenting with parathyroid hormone-related
protein-dependent hypercalcaemia
Abdalla T, Rieck G, Leeson S, Wayte D, Owen A, Adams C & Wilton
A |
| P37 |
A
case of ectopic ACTH with severe opportunistic infection
Hatfield ECI, Pal S, Meeran K, Williams G & Todd JF |
| P38 |
Clinical
features of phaeochromocytomas presenting as crises to an intensive care
unit
Sibal L, Peaston R, Lennard T & Perros P |
| P39 |
Coexisting
struma ovarii and Graves' disease
Teale EA & Peacey SR |
| P40 |
Testosterone
implant therapy: An audit of patients' views
Sturrock AM, Brothwood T & Bouloux P-MG |
| P41 |
Incidental
non-secretory pituitary adenoma in a case of ectopic ACTH induced Cushing's
syndrome
Hay CJ, Adams JE, Teasdale GM & Wu FCW |
| P42 |
The
use of intravenous etomidate infusion in the acute control of life-threatening
hypercortisolaemia in a case of ACTH-dependent Cushing's syndrome
Hay CJ, Eddleston JM & Wu FCW |
| P43 |
Cortisol
producing pheochromocytoma in pregnancy
Rangan S, Baskar V & Jackson MA |
| P44 |
Cyclical
Cushing's syndrome associated with a pituitary gonadotrophinoma
Acharya S, Jones TH, Suliman M, Park C, Watson W, Abraham P & Bevan
JS |
| P45 |
Tumour
induced hypoglycaemia
Mc Quaid SE, Srinivasan S, Yeow TP, Rahman Y & Nolan JJ |
| P46 |
Acromegaly
with hyperprolactinaemia - marked response to cabergoline therapy in
a patient with a co-secreting tumour
Shah RV, McGowan BMC & Clements MR |
| P47 |
The
UK National Acromegaly Database
Carson MN |
| P48 |
An
unusual case of gynaecomastia
Koppada A, Nirodi GN & Imtiaz KE |
| P49 |
Pituitary
carcinoma presenting as an aggressive non-functioning adenoma
Gallagher L, Gattameneni R, Holland JP & Davis JRE |
| P50 |
Hirsutism
and subclinical Cushing's syndrome
Franke B, Foote J & Fisher R |
| P51 |
Adrenal
rest tissue of the testes: A case report
O'Shea LA, Hackett C, Lennon F, Firth R & Kinsley BT |
| P52 |
Concurrence
of primary hypothyroisism, epilepsy and benign intracranial hypertension
in an adult
Dashora UK & Kennedy RL |
| P53 |
Vanishing
sellar masses: Two case reports
Chillala J, Al Najjar Y & Issa BG |
| P54 |
Lymphocytic
hypophysitis: A case report
Yeow TP, McQuaid SE, Srinivasan S, Rahman Y & Nolan JJ |
| P55 |
Growth
hormone deficiency and pregnancy
Brackenridge AL, Breen L & Russell-Jones D |
| P56 |
An
occult cause of hirsutism
O'Mullane NM, Watson A & Bannerjee B |
| P57 |
Young
woman with galactorrhoea
Kashyap AS |
| P58 |
A
case of Carney complex with unusual presentation
Shakoor SKA, Lalloo F & Davis JRE |
| P59 |
Calcitonin
in nodular thyroid disease
Patel D & Johnston C |
| P60 |
Resolving
adrenal insufficiency following haemorrhage into a pituitary adenoma
Goulden PA & Panahloo A |
| P61 |
Androgenisation
during pregnancy - a case report
Darko DA, McClaverty C, Kyd P, Teoh TG & Robinson S |
| P62 |
Unexplained
profound transient hypocalcaemia in a young male
Lewandowski K, Barth JH & Belchetz PE |
| P63 |
An
unusual case of thyroid enlargement in pregnancy
Kos K, Warner D & West TET |
| P64 |
Persistent
hypoglycaemia associated with neoplasia: A case of Doege-Potter syndrome
Ravichandran S, Imtiaz KE & Naqvi N |
| P65 |
Empty
sella presenting as a syndrome of inappropriate antidiuretic hormone
secretion
Helmy AFA |
Comparative |
| P66 |
Sheehan's
syndrome and non-functioning pituitary adenoma - a comparison of clinical
characteristics and response to growth hormone replacement
Goth MI, Auernhammer C, Colak R, Gomez JM, Molvalilar S & Kelestimur
F |
| P67 |
Prostaglandins
modulate the renal actions of antidiuretic hormone in the Peking duck
Gray DA |
| P68 |
Do
plasma osmolality methods meet clinical requirements?
Twomey PJ, Don-Wauchope AC & McCullough DA |
| P69 |
Analysis
of human renal chloride channel (hCLC-5) mutations based on a three-dimensional
model, suggests a structural-functional relationship
Wu F, Roche P, Christie PT, Loh NY, Reed AAC, Esnouf RM & Thakker
RV |
Cytokines and growth factors |
| P70 |
Growth
hormone (GH) insensitivity due to a mutation in the cytoplasmic domain
of the GH receptor distal to Box 1
Milward AD, Metherell L, Maamra M, Wilkinson IR, Camacho-Hubner
C, Savage MO, Ross RJM, Clark AJL & Webb SM |
| P71 |
A
growth hormone receptor (GHR) - glycophosphatidylinositol (GPI) chimera
acts as a receptor antagonist
Gavalas NG, Pradhananga SL, Beghadi C, Maamra M, Zarkesh-Esfahani
H, Sayers J, Artymiuk P, Reymond C & Ross RJM |
| P72 |
Relationships
between IL-6 levels and anthropometric, metabolic and hormonal parameters
in women with PCOS and the effect of treatment with metformin
Tsilchorozidou T, Mohamed-Ali V & Conway GS |
| P73 |
Increased
angiogenesis but not lymphangiogenesis in parathyroid proliferative lesions:
A possible role for FGF-2
Garcia de la Torre N, Wass JAH, Buley I, Jackson DG & Turner
HE |
| P74 |
Leptin
enhances expression of CD11b by human neutrophils through TNF-a
Zarkesh-Esfahani H, Pockley AG, Hellewell PG, Weetman AP & Ross
RJM |
| P75 |
Overexpression
of somatostatin receptors 1 and 5, and VEGF and its receptors FLK and
FLT in laryngeal carcinoma: Potential targets for anti-tumoral therapy?
Condon LT, Rogers MJC, Macdonald AW, Stafford ND & Atkin SL |
| P76 |
Development
of a bioassay for leptin agonists and antagonists
Fazeli M, Zarkesh-Esfahani H, Maamra M, Justice S & Ross RJM |
| P77 |
Serum
concentrations of interleukin-18 and tumour necrosis factor alpha are
associated to the features of the metabolic syndrome X in adults
Olusi SO |
| P78 |
Concentrations
of serum Interleukin-18, tumour necrosis factor alpha and plasma malondialdehyde
are associated with body mass index in healthy adults
Olusi SO |
Diabetes, metabolism and cardiovascular |
| P79 |
Identification
of the gene causing familial juvenile hyperuricaemic (Gouty) nephropathy
Stacey JM, Turner JJO, Harding B, Kotanko P, Lhotta K, Puig JG,
Roberts I, Torres RJ & Thakker RV |
| P80 |
Influence
of the Y chromosome on inter-individual variation in cholesterol serum
levels of young men
Charchar FJ, Tomaszewski M, Lacka B, Zakrzewski J, Zukowska-Szczechowska
E, Grzeszczak W & Dominiczak AF |
| P81 |
Effects
of the 11beta hydroxysteroid dehydrogenase inhibitor carbenoxolone on
insulin sensitivity in human obesity
Sandeep TC, Andrew R, Homer NZM & Walker BR |
| P82 |
Effect
of grape procyanidins on proliferation and apoptosis of pancreas beta
cells
Zhong Jinyi |
| P83 |
Testosterone
is a dilator of resistance arteries in men with congestive heart failure
Malkin CJ, Pugh PJ, Jones RD, Jones TH & Channer KS |
| P84 |
Orlistat
use outside of clinical trials: The Irish experience
Tuthill A, Kelly R, Ryan Y & O'Shea D |
| P85 |
Adrenomedullin
and proadrenomedullin N-terminal 20 peptide have opposing effects on
CRLR gene expression in human adrenal cells
Vakharia K & Hinson JP |
| P86 |
Autosomal
dominant neurohypophyseal diabetes insipidus associated with a glutamine47 deletion
Alcocer L, Boxer M, Connell JM & Ahmed SF |
| P87 |
Circulating
IGFBP-3 concentration is independently associated with insulin resistance
and BMI
Heald AH, Anderson S, Cruickshank JK & Gibson JM |
| P88 |
Mechanisms
of splicing inhibition in apolipoprotein B exon 26 (ApoB ex26)
Khoo B, Akker SA & Chew SL |
| P89 |
OGIS:
An index of insulin sensitivity in a clinical setting
Rahman Y, McQuaid S, Yeow TP & Nolan J |
| P90 |
Paradoxical
correlation between serum zinc and neutrophil respiratory burst in the
resting and stimulated states in type 2 diabetic patients with foot ulcers
Larijani B, Mossafa N, Shooshtarizadeh P, Nourai M, Vassigh AR,
Javadi E & Shafaee AR |
| P91 |
Baseline
clinical characteristics and response to growth hormone replacement therapy
in adults with isolated growth hormone deficiency in comparison with
multiple pituitary hormone deficiencies
Waterhouse M, Laureiro R, Walker D, Besser GM & Monson JP |
| P92 |
Cardiovascular
risk factors in obese children and their association with insulin resistance
Sabin MA, Crowne EC & Shield JPH |
| P93 |
Reduced
insulin sensitivity in healthy glucose tolerant first degree relatives
of patients with type 2 diabetes mellitus
Raskauskiene D |
| P94 |
Glycaemic
control, weight change and treatment: Examining the relationship in type
2 diabetes
Tuthill A, Curran S, McKenna M, O'Shea D & McKenna TJ |
| P95 |
Subcutaneous
and visceral preadipocytes from pre-pubertal children show site-specific
differences in insulin action
Grohmann MJ, Sabin MA, Holly JMP, Shield JPH, Crowne EC & Stewart
CEH |
| P96 |
The
effect of menopausal status on the biological variation of insulin resistance
Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA & Atkin
SL |
| P97 |
Altered
insulin sensitivity and secretion in Sotos syndrome
Nag S, Bennett SMA, Gerrard J, Walker M & Ball S |
| P98 |
The
predictive factors for gestational diabetes mellitus and postpartum diabetes
mellitus
Larijani B, Hossein-nezhad A, Pajouhi M & Bastanhagh MH |
| P99 |
Hypertension
in diabetics and non-diabetics; degree of blood pressure control and
antihypertensive agents
Akbar DH & Algamdi AA |
| P100 |
Treatment
of coronary disease and effects on endogenous testosterone levels
Malkin CJ, Pugh PJ, Jones TH & Channer KS |
| P101 |
Octreotide
LAR - a patient and nurse perspective
Thornton-Jones VA, Turner HE & Wass JAH |
| P102 |
Early
onset type 2 diabetes in an Irish population
McQuaid SE, Rahman Y, Yeow TP, O'Gorman DJ, Gasparro D, Yousif O & Nolan
JJ |
| P103 |
A
5 year retrospective analysis of diabetes ketoacidosis
Yeow TP, McQuaid SE, Rahman Y & Nolan JJ |
| P104 |
Type
2 diabetes in Alstrom syndrome: Targeting insulin resistance with a thiazolidinedione
Nag S, Kelly WF, Walker M & Connolly V |
| P105 |
Polycystic
ovary syndrome (PCOS) in Sri Lankans
Wijeyaratne CN, Balen AH, Barth JH & Belchetz PE |
| P106 |
Metformin:
Its effect on weight loss in obese patients with or without polycystic
ovary syndrome
Mukhtar RY, Pettit A & Robinson AM |
| P107 |
Mass
screening for diabetes: New horizon with computer aided diagnosis system?
Rahman Y, McQuaid S, Yeow TP, Knape T, Gargan M, Wade V, Nolan J & Grimson
J |
| P108 |
Hypopituitarism
presenting as hypoglycaemia in type 2 diabetes
Newey P & Jamieson A |
| P109 |
Blood
stream infections are common in admitted diabetics
Akbar DH |
| P110 |
Timing
of insulin administration amongst diabetic patients
Mountford CG, McCulloch AJ & Nag S |
| P111 |
Abnormal
immunoglobulin A and D levels in children with type 1 diabetes
Haroun M & Brzeski H |
| P112 |
The
effect of blood glucose in non-diabetic pregnant women on their infants'
weight
Vasegh F & Shahri P |
| P113 |
Unusual
causes for hypokalaemia in diabetics
Solomon AM & Cunnah DTE |
Endocrine tumours and neoplasia |
| P114 |
Familial
isolated primary hyperparathyroidism due to germline multiple endocrine
neoplasia Type 1 (MEN1) mutations
Turner JJO, Pannett AAJ, Kennedy AM, Forbes SA, Cavaco BM, Bassett
JHD, Cianferotti L, Harding B, Shine B, Flinter F, Maidment CGH, Trembath
R & Thakker RV |
| P115 |
Prostate
and ovarian cancer cell responses to treatment with 2-substituted oestrogen
sulphamates in vitro
Day JM, Newman SP, Comninos A, Solomon C, Purohit A, Leese MP, Potter
BVL & Reed MJ |
| P116 |
Dysregulated
extra-renal synthesis of 1,25-dihydroxyvitamin D3: A novel
cause of hypercalcemia associated with ovarian dysgerminomas
Evans KN, Zehnder D, Kilby MD, Taylor H & Hewison M |
| P117 |
Parathyroid
tumours harbour parafibromin somatic mutations, consistent with the Knudson
'two-hit' hypothesis
Cavaco BM, Bradley KJ & Thakker RV |
| P118 |
Genetic
abnormalities in carcinoid tumours
Leotlela PD, Turner JJO, Holtgreve-Grez H, Jauch A & Thakker
RV |
| P119 |
Hyperparathyroidism-jaw
tumour syndrome (HPT-JT) in Romany families from Portugal is due to a
founder mutation of parafibromin
Cavaco BM, Guerra L, Carvalho D, Bradley KJ, Harding B, Kennedy
AM, Santos MA, Sobrinho LG, Thakker RV & Leite V |
| P120 |
Clinical
and biochemical prognostic indicators at diagnosis in 117 midgut carcinoid
tumours
Turner GB, Johnston BT, McCance DR, Watson RGP, Buchanan KD & Ardill
JES |
| P121 |
Differential
modulation of key steroidogenic enzymes through orphan nuclear transcriptional
regulation may control the diverse production of cortisol and adrenal
androgens
Kelly SN, Mason JI, Mc Kenna TJ & Young LS |
| P122 |
IL1
alpha, IL6 and MMP13 are required for invasion by the human pituitary
cell line HP75
Borg SA, Royds JA & Jones TH |
| P123 |
Preoperative
determination of serum thyroglobulin may identify patients with differentiated
thyroid cancer who might recur without increased thyroglobulin
Gibelli B, Tradati N, Tredici P, De Cicco C, Bodei L, Sandri MT & Chiesa
F |
| P124 |
Acromegaly:
A study of epidemiological characteristics and treatment outcomes
Brown CK, Sampson MJ, Greenwood RH, Heyburn PJ & Temple RC |
| P125 |
Dysregulation
of the vitamin D axis in colorectal cancer
Ogunkolade BW, Kelly PJ, Khalaf S, Fairclough PD, Bustin SA & Jenkins
PJ |
| P126 |
Outcomes
in acromegaly: A retrospective study of 419 patients from the West Midlands
region of the United Kingdom
Ayuk J, Clayton RN, Sheppard MC, Stewart PM & Bates AS |
| P127 |
Proliferative
regulation of human breast cancer cells by dietary phytoestrogens: Mechanisms
of estrogen receptor-mediated signalling
Limer JL & Speirs V |
| P128 |
CYP27b
and CYP24 expression combine to determine 1,25 dihydroxyvitamin D3 insensitivity
in breast cancer cells
Townsend K, Banwell CM, Stewart PM, Hewison M & Campbell MJ |
| P129 |
Stable
iodide and radioiodide transport in extrathyroidal tissues
Clarke C, Brennan CG, Rodgers K, Dwyer RM & Smyth PPA |
| P130 |
Identification
of the ACTH receptor in the human pituitary and its loss of expression
in pituitary adenomas
Morris DG, Kola B, Borboli N, Kaltsas GA, Gueorguiev M, Jones TH,
Baldeweg S, Powell M, Korbonits M & Grossman AB |
| P131 |
The
presence of ghrelin protein in the rat hypothalamus and the effect of
ghrelin on corticotrophin releasing hormone (CRH) and arginine vasopressin
(AVP) release from rat hypothalamic explants pituitary tumours
Mozid AM, Tringali G, Forsling ML, Hendricks M, Ajodha S, Edwards
R, Navarra P, Grossman AB & Korbonits M |
| P132 |
Pituitary
tumor transforming gene upregulates its binding factor PBF in vitro
Stratford AL, Khanim F, Boelaert K, Gittoes NJL, Franklyn JA & McCabe
CJ |
| P133 |
Insulin-like
growth factor binding protein-3 (IGFBP-3) expression in the caecum and
rectum of patients with, and without, acromegaly
Khalaf S, Kelly P, Ogunkolade BW, Fairclough PD, Bustin SA & Jenkins
PJ |
| P134 |
Expression
of IGF-I in normal and malignant breast tissue and its association with
tumour size
Laban CA, McCarthy K, Ogunkolade W, Bustin SA, Carpenter R & Jenkins
PJ |
| P135 |
Expression
of IGFBP-3 mRNA in breast cancer in relation to clinical phenotype
McCarthy K, Ogunkolade W, Laban CA, Khalaf S, Bustin SA, Carpenter
R & Jenkins PJ |
| P136 |
Methylation
status and iodide uptake
Brennan CG, Dwyer RM, Clarke C & Smyth PPA |
| P137 |
Prolactinoma
volume and serum prolactin level: Evidence for the 'silent lactotroph'
tumour
Levy MJ, Thompson P, Powell M & Ahlquist JA |
| P138 |
Lipocortin-1
expression within normal and abnormal endometrium
Bedford KJ, Richmond I, Taylor AD & Atkin SL |
| P139 |
Co-regulators
SRC-1 and SMRT interact with ER-alpha and ER-beta in human breast cancer
Fleming FJ, Hill ADK, Mc Dermott EW, O'Higgins N & Young LS |
| P140 |
Pituitary
irradiation for recurrent steroid-responsive hypophysitis in three patients
Coyle F, Beaney R, Miell J, Bullock P, Al-Sarraj S, McGregor AM & Aylwin
SJB |
| P141 |
Abnormal
expression of 11beta-hydroxysteroid dehydrogenase 2 in primary cultures
of human pituitary adenomas
Rabbitt EH, Bujalska IJ, Stewart PM, Hewison M & Gittoes NJL |
| P142 |
Cell
cycle dysregulation in parathyroid adenoma and carcinoma
Valentine G, Jordan S, Lu X, Lowe DG, Hirace R, Korbonits M & Grossman
AB |
| P143 |
Transcriptional
regulation by PEA3 in human breast cancer
Myers E, Buggy Y, Hill ADK, Duffy MJ, O'Higgins N & Young LS |
| P144 |
Metaiodobenzylguanidine
scintigraghy (MIBG) and familial screening are not useful in phaeochromocytoma
Gardner SG, Amin R, Atkinson CJ, Turner HE & Wass JAH |
| P145 |
Molecular
genetic diagnosis for disorders of calcium metabolism
Cranston T, Huson SM, Seller A & Thakker RV |
| P146 |
Expression
of somatostatin receptors in proliferating and quiescent endothelial
cells
Adams RL, Adams IP & Atkin SL |
| P147 |
Abstract
withdrawn |
| P148 |
A
TSH response to a single octreotide test dose predicts a long term response
to somatostatin analogue therapy in patients with a TSH-secreting pituitary
adenoma
Bingham E, Alcock CR, Miell J, Harris PE, McGregor AM & Aylwin
SJB |
| P149 |
Usefulness
of growth hormone response to a test dose of subcutaneous octreotide
in predicting longer-term response to the drug. Poor responses predict
the need for adjuvant therapy to achieve 'safe' growth hormone levels
Lindsay JR, McConnell EM, Hunter SJ, McCance DR, Sheridan B & Atkinson
AB |
| P150 |
Expression
of vascular endothelial growth factor and its receptors in human anterior
pituitary adenomas
Adams IP, Henderson R, Green VL, Foy PM, Macfarlane I & Atkin
SL |
| P151 |
IGF-I
inhibits COX-2 function in primary colonic biopsies of patients with
acromegaly
Kelly PA, Vojnovic I, Fairclough PD, Warner T, Bustin SA & Jenkins
PJ |
| P152 |
Can
petrosal sinus ACTH and prolactin responses to CRH help localize the
tumour in Cushing's disease due to pituitary microadenomas?
Daousi C, Nixon T, Hayden C, Foy PM, Diver M & MacFarlane IA |
| P153 |
A
rapid method for analysing serum pro-insulin-like growth factor-II (pro-IGF-II)
in patients with non-islet cell tumour hypoglycaemia (NICTH)
Miraki-Moud F, Monson JP, Besser GM, Grossman AB & Camacho-Hübner
C |
| P154 |
A
new role for the endocrine nurse within a multidisciplinary approach
to neuroendocrine tumours
Stewart SE |
| P155 |
Transsphenoidal
surgery for acromegaly in Wales: Results based on stringent criteria
of remission
De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies
JS & Scanlon MF |
| P156 |
Carney
complex type 1 gene (PRKAR1A) expression and sequence analysis in sporadic
somatotroph and other pituitary tumours
Borboli N, Kaltsas GA, Kola B, Gueorguiev M, Czirják S, Kirschner
L, Stratakis SA, Korbonits M & Grossman AB |
| P157 |
Elevated
alpha fetoprotein levels in association with a metastatic neuroendocrine
tumour
Hanna GG, Cross M, Ardill J, Johnston BT & McCance DR |
| P158 |
Retrospective
audit of care of patients undergoing pituitary surgery in Plymouth
Wotherspoon F, Dyer RG & Pobereskin L |
| P159 |
Lymphocytic
adenohypophysitis occurring simultaneously with an ACTH secreting adenoma
Cuthbertson DJR, Carey P, Ritchie D, Rossi M & Vora J |
| P160 |
Double
trouble: Dual pathology and false positive as well as false negative
imaging in a man with phaeochromocytoma and hypogonadism
Jacob K, Ganesaratnam S & Winocour P |
Growth and development |
| P161 |
Testosterone
enhances the effect of growth hormone (GH) to increase IGF-I but exerts
an anabolic effect that is independent of GH action
Gibney J, Wolthers T, Males M, Smythe G, Umpleby AM & Ho KKY |
| P162 |
GATA3
missense mutation disrupts interaction with friend of GATA 2 (FOG2) and
causes the hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome
Nesbit MA, Bowl MR, Ali A & Thakker RV |
| P163 |
Identification
of GATA3 zinc finger 1 residues that are important for interactions with
friend of GATA 2 (FOG2)
Ali A, Nesbit MA & Thakker RV |
| P164 |
A
potential role for human securin/PTTG in the developing human fetal brain
Boelaert K, McCabe CJ, Tannahill LA, Bulmer JN, Chan SY, Gittoes
NJ, Sheppard MC, Kilby MD & Franklyn JA |
| P165 |
A
unique sequence element that silences the growth hormone receptor (GHR)
pseudoexon
Akker SA, Khoo B, Metherell LA, Clark AJL & Chew SL |
| P166 |
A
novel mutation within the conserved EH-1 domain of HESX1 causes evolving
CPHD due to the loss of interaction with the co-repressor TLE1
Woods KS, Carvalho L, Zamparini AL, Stifani S, Marcal N, Turton
JPG, Mendonca BB, Brickman JM, Arnhold IJ & Dattani MT |
| P167 |
The
use of a specific questionnaire to assess quality of life in growth hormone
deficient adults
Sathiavageeswaran M, Bisp K & Wass JAH |
| P168 |
Differential
regulation of the ghrelin promoter in WRL68 and HEK293 cells
Macartney DP, Hughes BA, Stewart PM, Sheppard MC & Toogood AA |
| P169 |
Expression
and distribution of the prolactin-receptor in healthy, fibrotic and cirrhotic
liver in rats and humans
Kloehn S, Simon-Holtorf J, Bachmann J & Mönig H |
| P170 |
Regulation
of Wolffian duct development in patients with complete androgen insensitivity
syndrome
Hannema SE, Martin H & Hughes IA |
| P171 |
The
effect of chronic administration of recombinant (human) leptin on leptin
and uncoupling protein (UCP) 2 mRNA in neonatal pigs
Litten JC, Perkins KS, Bell M & Clarke L |
| P172 |
Adults
with partial growth hormone (GH) deficiency have an adverse body composition
Murray RD, Adams JE & Shalet SM |
| P173 |
The
effect of chronic administration of recombinant (human) leptin on the
growth performance of neonatal pigs
Litten JC, Bell M, Perkins KS & Clarke L |
| P174 |
The
effect of maternal dietary supplementation during late gestation on the
growth performance of intra-uterine growth restricted (IUGR) pigs
Perkins KS, Litten JC, Corson AM, Laws J & Clarke L |
| P175 |
The
use of combined GHRH and arginine test in the diagnosis of growth hormone
deficiency in successfully treated acromegalics
Sathiavageeswaran M, Bisp K & Wass JAH |
| P176 |
Cessation
of growth hormone (GH) results in loss of lean body mass and reduced
accrual of bone mass in adolescents with severe GH deficiency - 2 year
follow up
Carroll PV, Drake WM, Maher KT, Metcalfe K, Savage MO, Dunger DB,
Shaw NJ, Camacho-Hubner C & Monson JP |
Neuroendocrinology and behaviour |
| P177 |
Galanin-like
peptide interactions with leptin and GnRH
Seth A, Stanley SA, Ghatei MA & Bloom SR |
| P178 |
Insulin
sensitivity improves in patients with acromegaly converted from depot
octreotide (Sandostatin LAR) to pegvisomant
Drake WM, Rowles SV, Roberts ME, Fode FK, Besser GM, Monson JP & Trainer
PJ |
| P179 |
Intracerebroventricular
ghrelin injection acutely stimulates food intake and inhibits luteinising
hormone secretion in sheep
Harrison JL, Findlay PA, Miller DW & Adam CL |
| P180 |
Intra-hypothalamic
gene transfer of cocaine- and amphetamine-regulated transcript results
in increased food intake and weight gain
Ward HL, Gardiner JV, Smith KL, Kong WM, Martin NM, Small CJ, Ghatei
MA & Bloom SR |
| P181 |
A
randomised double-blind cross-over study of GH treatment in patients
over 60 years
Mah PM, Walters SJ, Newell-Price JD, Webster J, Doane A, Ibbotson
V, Hosker JP, Jones TH, Ho KK, Eastell R & Ross RJ |
| P182 |
Hypopituitarism
following cranial irradiation for non-pituitary brain tumours
Agha A, O'Connor S, Rogers B & Thompson CJ |
| P183 |
Serum
leptin, insulin, IGF- levels and body composition in partially and fully
recovered patients with anorexia nervosa
Djurovic M, Petakov M, Damjanovic S, Pekic S, Glisic B, Miljic D,
Doknic M, Dieguez C, Casanueva F & Popovic V |
| P184 |
Differential
effects of the route of testosterone administration on GH sensitivity
and bone mineral density in hypopituitarism
Brooke AM, Carroll PV, Walker D, Besser GM & Monson JP |
| P185 |
Abnormal
endocrine tests in chronic pain require investigation and are not the
result of opioid analgesia
Merza Z, Edwards N, Walters S, Newell-Price J & Ross RJM |
| P186 |
Effect
of the novel somatostatin ligand, SOM230, on rat and human anterior pituitary
hormone secretion
Murray RD, Kim K, Ren SG, Weckbecker G, Bruns C & Melmed S |
| P187 |
Pituitary
apoplexy: A review of presentation, management and outcome
Vaidya B, Sibal L, Kane P, Brady N, Connolly V, James RA & Kelly
W |
| P188 |
Treating
hyperprolactinaemia: Where to draw the line?
Qureshi AI, Bano G & Nussey SS |
| P189 |
Treatment
outcome in acromegaly: Results from the Beaumont Hospital pituitary database
Agha A, Ng S, Rogers B, Philips J & Thompson CJ |
| P190 |
Single
centre audit of surgical outcome in acromegaly
Baldeweg SE, Conway GS, Powell M & Vanderpump M |
| P191 |
Problematic
development of an immunometric assay for cocaine and amphetamine regulated
transcript (CART) (55-102) peptide fragment
Darch SJ, Chapman RS, Murphy KG & Bloom SR |
| P192 |
Audit
of quality of life in individuals who have undergone treatment for pituitary
tumours over the past ten years at a single neurosurgical centre
Fowler HL, Ghosh S, Buckler H & Heald AH |
Reproduction |
| P193 |
Maternal
and neonatal outcomes after conception during cabergoline therapy for
hyperprolactinaemia
Booth SA, Philip S, Middleton M, Park CM, Abraham P & Bevan
JS |
| P194 |
Insulin
sensitivity in polycystic ovary syndrome -influence of peroral versus
transdermal estrogen treatment
Vrbikova J, Stanicka S, Dvorakova K, Hill M, Vondra K & Starka
L |
| P195 |
Oxygen
tension regulates placental 11beta-hydroxysteroid dehydrogenase type
2
Driver PM, Hewison M, Kilby MD & Stewart PM |
| P196 |
Clinical
features of patients with macroprolactinaemia
Teoh WL, Strachan M, Don-Wauchope A, Beckett GJ, Stoddart M & Seth
J |
| P197 |
Hypoxia
influences steroid and nitric oxide production in swine granulosa cells
Bianco F, Grasselli F, Basini G, Tirelli M, Bussolati S, Cavalli
V & Tamanini C |
| P198 |
Effect
of aroclor 1242 (PCB) on the reproductive function of adult male rhesus
monkey (Macaca mulatta)
Ahmad MM, Ahmad SU & Tariq S |
| P199 |
Treatment
of hypogonadotropic hypogonadism in women with neuroendocrine disorders
Ilovaiskaia IA, Pischulin A & Marova EI |
| P200 |
Biological
variation of free androgen index and bioavailable testosterone in PCOS:
Implications for estimation of hyperandrogenaemia
Jayagopal V, Diver MJ, Kilpatrick ES, Jennings PE & Atkin SL |
| P201 |
Screening
for iron deficiency and anaemia in adults with Turner syndrome
Ostberg JE & Conway GS |
| P202 |
Complications
of testosterone replacement in men with primary and secondary hypogonadism
Meston N, Turner HE & Wass JAH |
| P203 |
A
more rigorous laboratory definition of macroprolactinaemia with clinical
significance
Smith TP, Gibney J, Kavanagh L, Dickinson A & McKenna TJ |
| P204 |
The
effect of insulin-like growth factor-I (IGF-I) on initiation of human
follicle growth in vitro
Stubbs S, Zachery-Jennings C, Margara R, Trew GM, Franks S & Hardy
K |
| P205 |
Effects
of CAG repeat expansion of the androgen receptor and its truncation on
neural and non-neural cells
Wong JM, Zajac JD, Warne GL & Greenland KJ |
| P206 |
Sexual
dimorphism in fetal testosterone output in the silver fox
Osadchuk LV |
| P207 |
Polycystic
ovary syndrome (PCOS) has a significant negative impact on health-related
quality of life (HRQoL)
Coffey S, Bano G & Mason H |
| P208 |
Pharmacokinetics
and tolerability of a new bioadhesive buccal testosterone tablet in testosterone
deficient men
Ross RJM, Jabbar A, Jones H, Roberts B, Dunkley K, Long A, Levine
H & Cullen DR |
| P209 |
Immunopurification
of gonadotrophin surge-attenuating factor (GnSAF) bioactivity
Sorsa-Leslie T, Harris WJ, Mason HD & Fowler PA |
| P210 |
Comparison
between azoospermic responders and oligozoospermic non-responders to
sex steroidal contraception: A pharmacogenetics study examining the androgen
receptor, CYP17, LHbeta and 5alpha-reductase-2 genes
Oxynos C, Thakker N, Hewitt C, Southern L, Anderson RA, Huhtaniemi
IT, Yong EL & Wu FCW |
| P211 |
1,25-Dihyroxyvitamin
D3 has a direct effect on steroid production from human theca cells
Brain HPS, Bano G, Brincat M, Galea R, Pellatt LJ, Nussey SS & Mason
HD |
| P212 |
Evidence
for the use of metformin in women with polycystic ovary syndrome
Sattar N, Harborne L, Lyall H, Norman J & Fleming R |
| P213 |
Testosterone
pellet implants - an acceptable mode of androgen replacement
Swinburne J, Ward E & Belchetz PE |
| P214 |
Investigating
germ cell development and differentiation in the human fetal testis
Gaskell TL, Robinson LL, Anderson RA & Saunders PTK |
Steroids |
| P215 |
11Beta-hydroxysteroid
dehydrogenase in human fibroblasts: Expression and regulation depends
on tissue of origin
Moore J, Filer A, Buckley CD, Stewart PM, Hewison M & Cooper
MS |
| P216 |
Adipocyte
size increases with BMI, but is unrelated to 11 beta-hydroxysteroid dehydrogenase
type 1 expression
Tomlinson JW, Bujalska I, Collard M & Stewart PM |
| P217 |
Interactions
between 11beta-hydroxysteroid dehydrogenase type 1 and 5beta-reductase
Livingstone DEW, Reidy L, Drake AJ, Paterson JM, Walker BR & Andrew
R |
| P218 |
Studies
on functional activity of human ERbeta wild type and variant isoforms
Sierens J, Scobie GA, Wilson JA & Saunders PTK |
| P219 |
Mutagenesis
studies on recombinant human 11beta-hydroxysteroid dehydrogenase type
1
Walker EA, Hughes SV, Ride JP, Hewison M & Stewart PM |
| P220 |
The
relationalship of on-admission plasma cortisol to outcome in critical
illness: A longitudinal prospective study
Jaiswal V, Baudouin SV & Ball SG |
| P221 |
CYP7B
catalyses the 7alpha-hydroxylation of dehydroepiandrosterone in human
prostate
Martin CP, Ross M, Seckl JR & Habib F |
| P222 |
In
vitro expression of human aldosterone synthase and 11-beta hydroxylase
Inglis GC, Davies E, Fraser R & Connell JMC |
| P223 |
Excretion
of the urinary metabolite of deoxycortisol is heritable and influenced
by polymorphic variation at the CYP11B2 (aldosterone synthase) locus
Myosi B, Keavney B, Watkins H, Davies E, Ingram M, Fraser R & Connell
J |
| P224 |
Differential
regulation of vitamin D receptor and its ligand in human dendritic cells:
A paracrine mechanism for regulation of antigen presentation
Freeman L, Evans K, Hughes SV, Moss P, Chakraverty R & Hewison
M |
| P225 |
High
prevalence of low testosterone levels in men with coronary heart disease
and an association with hypertension and obesity - the South Yorkshire
study
Pugh PJ, Morris PD, Hall J, Malkin CJ, Asif S, Jones RD, Channer
KS & Jones TH |
| P226 |
Identification
of glucocorticoid target genes in human subcutaneous and omental adipose
tissue using microarray analysis
Bujalska IJ, Montague CT, Smith DM & Stewart PM |
| P227 |
The
5' untranslated region of the rat glucocorticoid receptor contains elements
important for cell-specfic promoter activity and glucocorticoid regulation
Munn HL, Lyons V, McCormick JE, Seckl JR & Chapman KE |
| P228 |
Activation
of the hypothalamic-pituitary-adrenal axis in adult women with low birthweight
Reynolds RM, Walker BR, Syddall HE, Andrew R, Wood PJ & Phillips
DIW |
| P229 |
Regulation
of aldosterone synthase (CYP11B2) gene expression in the rat adrenal
gland and central nervous system by sodium and angiotensin II
Ye P, Kenyon CJ, MacKenzie SM, Fraser R, Connell JMC & Davies
E |
| P230 |
Beneficial
affects of regular exercise: Is it all in the hormones?
Andrews RC & Wood P |
| P231 |
Development
of a mouse hypertension model induced by aldosterone excess
Marshall E, Speirs HJL, Coan SK, Mullins JJ, Kenyon CJ & Brown
RW |
| P232 |
Urinary
18-hydroxycortisol: Diagnostic utility of three methods compared
Reynolds RM, Sandhu K, Shakerdi LA, Wallace AM, Wood PJ & Walker
BR |
| P233 |
In
vitro
Shakerdi LA, Friel EC, Davies E, Connell JMC, Wallace AM & Fraser
R |
| P234 |
Aldosterone
synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) gene expression in
the normal and failing rat heart
Millar CA, Ye P, Gray GA, Wallace AF, MacKenzie SM, Fraser R, Connell
JMC & Davies E |
| P235 |
Cardiovascular
risk assessment in bodybuilders abusing anabolic steroids
Lane HA, Grace F, Lewis J, Morris K, Thomas AW, Scanlon MF, Davies
JS & Cockroft J |
| P236 |
Regulation
of the human 11beta-hydroxysteroid dehydrogenase gene by glucocorticoids
Bedendo O, Bujalska IJ, Draper N, Walker EA, Hewison M, Mantero
F & Stewart PM |
| P237 |
Cortisol
metabolite excretion and 11-hydroxysteroid dehydrogenase type 1 activity
are strongly heritable in man
Myosi B, Watkins H, Keavney B, Ingram M, Fraser R, Davies E & Connell
J |
| P238 |
Contrasting
acute and chronic changes in glucocorticoid action during high fat feeding
in rats
Drake AJ, Livingstone DEW, Reidy L, Andrew R, Morton NM, Seckl JR & Walker
BR |
| P239 |
Effect
of dietary sodium manipulation on aldosterone synthase (CYP11B2) gene
expression in the rat cardiovascular system
Ye P, Kenyon CJ, MacKenzie SM, Fraser R, Connell JMC & Davies
E |
| P240 |
Is
the cortisol day curve a useful tool?
Evans PA, Wilkin TJ, Jeffery J, Williams R & Flanagan DE |
| P241 |
Urinary
steroid hormone metabolites in patients with porphyrias
Christakoudi S, Deacon AC, Peters TJ & Taylor NF |
| P242 |
Functional
analysis of the N/C interactions in the AR
Stol K, Martin H, Jaaskelainen J & Hughes IA |
| P243 |
Insulin
sensitivity and hypoglycaemic susceptibility in children with endocrinopathies
reflects the underlying hormone deficiency and treatment regimen
Johnstone HC, Bartlett K & Cheetham TD |
| P244 |
Bilateral
massive adrenal enlargement in a poorly treated adult patient with salt
losing congenital adrenal hyperplasia
Nagi DK, Ajjan R, Andrew J, Walker P, Ismail A & Jenkins R |
| P245 |
Audit
of adrenal vein sampling for primary aldosteronism
Sibal L, Raza A, Leen B & Kelly W |
| P246 |
Testosterone
reduces free radical release from human monocytes
Lane HA, Smith J, Rathbone N, Morris K, Thomas A, Scanlon MF & Davies
JS |
| P247 |
Can
random urine samples substitute for 24 hour collections for steroid profiling?
Jerjes WK & Taylor NF |
| P248 |
A
non-invasive test of mild glucocorticoid resistance
Jerjes WK, Wood PJ & Taylor NF |
| P249 |
Mutations
in the HSD11B2 gene causing AME in the Oman population
Atterbury AJ, Draper N, Lavery GG, Walker EA, DeSilva V, Taylor
NF, Hala S, Rajendra N, Bappal B & Stewart PM |
| P250 |
Isolated
ACTH deficiency precipitated by silent thyroiditis presenting as acute
metabolic acidosis
Ajjan R, Andrew J, Spilker C, Ismail A & Nagi DK |
| P251 |
Macroprolactinoma
and pituitary dependent Cushing's syndrome: An unusual combination with
response to dopamine agonist therapy
Ajjan R, Andrew J, Jenkins R, Walker P, Ismail A & Nagi DK |
| P252 |
The
influence of anticoagulant preservatives, time and posture in renin measurements
and estimation of aldosterone to renin ratio (ARR)
Al-Hashmi KM, Morton JJ, Elliott HL & Connell JM |
| P253 |
Assessment
of antiandrogenic activity in a range of environmental contaminants
Jones ER, Martin H, Acerini CL & Hughes IA |
Thyroid |
| P254 |
Thyroid
hormone receptor (TR) activity is modulated by TRdeltabeta3 in a cell-
response element- and TR isoform-specific manner
Harvey CB & Williams GR |
| P255 |
Preliminary
evidence for genetic heterogeneity in the autoimmune polyendocrinopathy
and enteropathy syndrome (IPEX)
Owen CJ, Jennings CE, Imrie H, Lachaux A, Bridges NA, Cheetham TD & Pearce
SHS |
| P256 |
The
type II and III iodothyronine deiodinase enzymes are expressed in differentiating
growth plate chondrocytes
Robson H, Shalet SM & Williams GR |
| P257 |
Does
iodide modulate the biological outcome of activating thyrotropin receptor
mutations?
Al-Khafaji F & Ludgate M |
| P258 |
The
W546X mutation of the thyrotropin receptor gene: Potential major contributor
to thyroid dysfunction in a caucasian population
Jordan NJ, Willliams N, Gregory JW, Evans C, Owen M & Ludgate
M |
| P259 |
The
expression of apoptotic genes in autoimmune thyroid diseases
Waheed S, Hammond LJ, Biro PA & Mirakian R |
| P260 |
Iodide
effects on iodide transport and organification in human thyroid cells in
vitro
Eggo MC & Black EG |
| P261 |
The
epidemiology of thyroid cancer in Scotland, 1960-1999
Weir J, Brewster DH & Strachan MWJ |
| P262 |
The
controlled antenatal thyroid screening study (CATS) - first observations
Lazarus JH, Wald NJ, Angele C, George LM, Seed PT, Taylor IL & Parkes
AB |
| P263 |
Cardiac
autonomic function in hyperthyroidism
Osman F, Daykin J, Chowdhary S, Sheppard MC, Gammage MD & Franklyn
JA |
| P264 |
Is
the thyroglobulin gene a susceptibility locus for autoimmune thyroid
disease in the UK?
Collins JE, Heward JM, Franklyn JA & Gough SCL |
| P265 |
Assessment
of UK Caucasian allele frequencies of known TNF-alpha polymorphisms and
their association with Graves' disease
Simmonds MJ, Nithiyananthan R, Heward JM, Franklyn JA & Gough
SCL |
| P266 |
Psychological
well-being in patients on 'adequate' doses of L-thyroxine
Saravanan P, Chau F, Roberts N, Vedhara K, Greenwood R & Dayan
CM |
| P267 |
Does
HLA-DRB1-DQA1-DQB1 genotype contribute to chronic autoimmune thyroiditis
development in adult patients with diabetes mellitus type 1?
Dvorakova K, Vondra K, Bendukidze N, Bendlova B, Ivaskova E, Sterzl
I, Vrbikova J & Zamrazil V |
| P268 |
A
managed clinical network for thyroid disease
Cuthbertson DJR, Jung RT & Leese GP |
| P269 |
Somatostatin
receptor expression in thyroid disease
England RJA, Bedford KJ, Karsai L & Atkin SL |
| P270 |
Adequacy
of information delivered to patients during consultation for thyrotoxicosis
Kaushal K, Bhattacharyya A, Varghese B & Davis JRE |
| P271 |
Serum
TSH and thyroid autoantibodies in thyroidal and extrathyroidal disease
Smyth PPA, Kavanagh D, Smith DF, Brennan CG, Fleming F, Hill ADK,
Mc Dermott EWM, O'Higgins NJ, Barrett P, Thompson C & Moriarty
MJ |
| P272 |
Comparison
of simultaneous ultrasonography and radio-isotope scanning in hyperthyroid
patients as compared with radio-isotope scanning alone
McGowan G, Skehan S, Collins C & O'Shea D |
| P273 |
Conventional
withdrawal of thyroid suppression in differentiated thyroid carcinoma:
How frequently are adequately raised TSH levels attained?
McLaughlin CM, Hunter SJ, Bell PM, McCance DR, Sheridan B & Atkinson
AB |
| P274 |
High
prevalence of ANCA in patients with Graves' disease treated with thionamides
Harper L, Chin L, Daykin J, Allahabadia A, Heward JM, Gough SC,
Savage CO & Franklyn JA |
| P275 |
Lack
of association of the interleukin 4 receptor gene with Graves' disease
in the UK
Tait KF, Heward JM, Kelly MA, Barnett AH, Franklyn JA & Gough
SCL |
| P276 |
Does
an eosinophil/monocyte ratio help to differentiate between types of thyrotoxicosis?
Sturrock AM & Hurel SJ |
| P277 |
Acute
metabolic effects of high dose intravenous methylprednisolone therapy
in patients with thyroid-associated ophthalmopathy
Ahmed A, Dickinson AJ, Neoh C, Frewin S & Perros P |
| P278 |
Graves'
disease presenting in the third trimester of pregnancy
McCulloch AJ, Wood R & Nag S |
| P279 |
Outcome
of carbimazole, radioactive iodine and subtotal thyroidectomy in the
treatment of Graves' disease at Alnour Hospital in Saudi Arabia
Karawagh AM & Abdelaziz MM |
| P280 |
Homocysteine
in subclinical hypothyroidism, a risk factor for atherosclerosis?
Andrees M, Boran G, Clarke G & O Connor G |
Novartis Awards Poster Session |
| This special session will take place at 12.45-13.15
on Tuesday 25 March in Hall 2. |
| NP1 |
Expression
of adiponectin protein in human fat: The effect of type 2 diabetes and
obesity
Fisher FFM, McTernan PG, McTernan CL, Chetty R, Harte AL, Valsamikis
G, Barnett AH & Kumar S |
| NP2 |
Abnormalities
of thyroid function in the POMC-null mouse
Martin NM, Small CJ, Sajedi A, Ghatei MA, Hochgeschwender U & Bloom
SR |